Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...

One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health ...

Innoviva’s zoliflodacin is a first-in-class, single-dose, oral spiropyrimidinetrione antibiotic currently under regulatory ...

Data highlighting potential of Nu-3 in mildly infected diabetic foot ulcer (iDFU) published in "Antimicrobial Agents and ...

Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

The market for pyelonephritis treatments presents opportunities in novel drug development, emphasizing advanced ESBL coverage and efficacy under acidic conditions. Key players include Wockhardt and ...

They are uncomfortable, annoying and occasionally dangerous. But fevers are also an essential part of how we protect ...

A type 2 diabetes medication may lower the risk of autoimmune rheumatic diseases like rheumatoid arthritis by 11%, unlike ...

They are uncomfortable, annoying and occasionally dangerous. But fevers are also an essential part of how we protect ...

The House of Representatives on Thursday urged the Federal Government, through the Nigeria Centre for Disease Control and ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...